SCHEMBL3555901

SCHEMBL3555901

CN(C)CCOc1c(-c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.58
HTR2C P28335 3/20 0.58
HTR6 P50406 3/20 0.48
HTR7 P34969 2/20 0.48
HTR1A P08908 1/20 0.48
HTR1D P28221 1/20 0.48
SLC6A4 P31645 1/20 0.48
HTR5A P47898 1/20 0.48
DRD2 P14416 1/20 0.48
HTR1B P28222 1/20 0.44
ACHE P22303 1/20 0.44
ALDH1A1 P00352 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3553981 0.86 PDE10A (0.59) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL3555171 0.86 PDE10A (0.50) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL3565415 0.86 TUBB4A (0.49) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL3563594 0.85 HTR6 (0.67) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL855097 0.85 TNKS (0.50) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL3556246 0.82 HTR6 (0.56) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL11790794 0.80 MAPT (0.53) HTR2AHTR2CHTR6ALDH1A1ESR1
SCHEMBL23876044 0.80 HTR7 (0.49) HTR2AHTR2CHTR6HTR7HTR1A
SCHEMBL12466150 0.80 ESR1 (0.50) HTR2AHTR2CDRD2ALDH1A1ESR1
SCHEMBL3558501 0.79 PDE10A (0.41) HTR2AHTR2CHTR6HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR2A 10/4885HTR2C 5/4885HTR6 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.